Literature DB >> 15894629

Helix packing and orientation in the transmembrane dimer of gp55-P of the spleen focus forming virus.

Wei Liu1, Evan Crocker, Stefan N Constantinescu, Steven O Smith.   

Abstract

gp55-P is a dimeric membrane protein with a single transmembrane helix that is coded by the env gene of the polycythemic strain of the spleen focus forming virus. gp55-P activates the erythropoietin (Epo) receptor through specific transmembrane helix interactions, leading to Epo-independent growth of erythroid progenitors and eventually promoting erythroleukemia. We describe the use of magic angle spinning deuterium NMR to establish the structure of the transmembrane dimer of gp55-P in model membranes. Comparison of the deuterium lineshapes of leucines in the center (Leu(396-399)) and at the ends (Leu(385), Leu(407)) of the transmembrane sequence shows that gp55-P has a right-handed crossing angle with Leu(399) packed in the dimer interface. We discuss the implications of the structure of the gp55-P transmembrane dimer for activation of the Epo receptor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15894629      PMCID: PMC1366604          DOI: 10.1529/biophysj.104.057844

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  49 in total

1.  The hydrophobic membrane-spanning sequences of the gp52 glycoprotein are required for the pathogenicity of Friend spleen focus-forming virus.

Authors:  R V Srinivas; D R Kilpatrick; S Tucker; Z Rui; R W Compans
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

2.  Conversion of Friend mink cell focus-forming virus to Friend spleen focus-forming virus by modification of the 3' half of the env gene.

Authors:  N Watanabe; M Nishi; Y Ikawa; H Amanuma
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

3.  Transmembrane domain of the envelope gene of a polycythemia-inducing retrovirus determines erythropoietin-independent growth.

Authors:  S W Chung; L Wolff; S K Ruscetti
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

4.  Activation of erythropoietin receptors by Friend viral gp55 and by erythropoietin and down-modulation by the murine Fv-2r resistance gene.

Authors:  M E Hoatlin; S L Kozak; F Lilly; A Chakraborti; C A Kozak; D Kabat
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

5.  Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor.

Authors:  J P Li; A D D'Andrea; H F Lodish; D Baltimore
Journal:  Nature       Date:  1990-02-22       Impact factor: 49.962

6.  Friend spleen focus-forming virus glycoprotein gp55 interacts with the erythropoietin receptor in the endoplasmic reticulum and affects receptor metabolism.

Authors:  A Yoshimura; A D D'Andrea; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

7.  Multimeric structure of the membrane erythropoietin receptor of murine erythroleukemia cells (Friend cells). Cross-linking of erythropoietin with the spleen focus-forming virus envelope protein.

Authors:  N Casadevall; C Lacombe; O Muller; S Gisselbrecht; P Mayeux
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

Review 8.  Molecular biology of Friend viral erythroleukemia.

Authors:  D Kabat
Journal:  Curr Top Microbiol Immunol       Date:  1989       Impact factor: 4.291

9.  Disulfide bonding controls the processing of retroviral envelope glycoproteins.

Authors:  B C Gliniak; S L Kozak; R T Jones; D Kabat
Journal:  J Biol Chem       Date:  1991-12-05       Impact factor: 5.157

10.  Env-derived gp55 gene of Friend spleen focus-forming virus specifically induces neoplastic proliferation of erythroid progenitor cells.

Authors:  S Aizawa; Y Suda; Y Furuta; T Yagi; N Takeda; N Watanabe; M Nagayoshi; Y Ikawa
Journal:  EMBO J       Date:  1990-07       Impact factor: 11.598

View more
  7 in total

1.  His499 Regulates Dimerization and Prevents Oncogenic Activation by Asparagine Mutations of the Human Thrombopoietin Receptor.

Authors:  Emilie Leroy; Jean-Philippe Defour; Takeshi Sato; Sharmila Dass; Vitalina Gryshkova; Myat M Shwe; Judith Staerk; Stefan N Constantinescu; Steven O Smith
Journal:  J Biol Chem       Date:  2015-12-01       Impact factor: 5.157

2.  An amphipathic motif at the transmembrane-cytoplasmic junction prevents autonomous activation of the thrombopoietin receptor.

Authors:  Judith Staerk; Catherine Lacout; Takeshi Sato; Steven O Smith; William Vainchenker; Stefan N Constantinescu
Journal:  Blood       Date:  2005-10-25       Impact factor: 22.113

3.  Solid state deuterium NMR study of LKα14 peptide aggregation in biosilica.

Authors:  Helen E Ferreira; Gary P Drobny
Journal:  Biointerphases       Date:  2017-06-27       Impact factor: 2.456

4.  Lipid-protein correlations in nanoscale phospholipid bilayers determined by solid-state nuclear magnetic resonance.

Authors:  Aleksandra Kijac; Amy Y Shih; Andrew J Nieuwkoop; Klaus Schulten; Stephen G Sligar; Chad M Rienstra
Journal:  Biochemistry       Date:  2010-11-02       Impact factor: 3.162

5.  Transmembrane helix orientation influences membrane binding of the intracellular juxtamembrane domain in Neu receptor peptides.

Authors:  Chihiro Matsushita; Hiroko Tamagaki; Yudai Miyazawa; Saburo Aimoto; Steven O Smith; Takeshi Sato
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-14       Impact factor: 11.205

6.  Tryptophan at the transmembrane-cytosolic junction modulates thrombopoietin receptor dimerization and activation.

Authors:  Jean-Philippe Defour; Miki Itaya; Vitalina Gryshkova; Ian C Brett; Christian Pecquet; Takeshi Sato; Steven O Smith; Stefan N Constantinescu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

7.  Coupling of transmembrane helix orientation to membrane release of the juxtamembrane region in FGFR3.

Authors:  Hiroko Tamagaki; Yusuke Furukawa; Ritsuko Yamaguchi; Hironobu Hojo; Saburo Aimoto; Steven O Smith; Takeshi Sato
Journal:  Biochemistry       Date:  2014-07-24       Impact factor: 3.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.